The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer
AUTOR(ES)
Padalecki, Susan S
FONTE
BioMed Central
RESUMO
The skeleton is the most common site of breast cancer metastases. These bone metastases are usually osteolytic and cause significant morbidity. Bisphosphonates, potent inhibitors of bone resorption, reduce skeletal morbidity in breast cancer patients with bone metastases. Animal studies with bisphosphonates are crucial to understanding the mechanisms by which these compounds affect bone and tumor cells in vivo. Such animal models of breast cancer that are used to test the efficacy of bisphosphonates are discussed. These studies may offer insight into the treatment of other tumor types that frequently metastasize to bone.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138714Documentos Relacionados
- The role of bisphosphonates in breast cancer: Development of bisphosphonates
- The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells
- The role of bisphosphonates in breast cancer: The present and future role of bisphosphonates in the management of patients with breast cancer
- Models of breast cancer: quo vadis, animal modeling?
- Models of breast cancer: is merging human and animal models the future?